Objectives
Cultivate an innovative ecosystem: Establish an environment that encourages and supports employee-driven innovation within the organization.
Effectiveness and measurability: Implement a framework to evaluate the success and impact of the innovation initiatives.
Value creation: Generate innovative ideas that provide significant value to customers, patients, and healthcare providers.
Approach
Spyre Group worked closely with AstraZeneca's management team to design and implement a program that would harness employee creativity and drive internal innovation. The following steps were taken:
Idea Generation: A structured process was implemented to solicit ideas from employees, encouraging them to propose innovative initiatives across various areas of the company's focus, including cancer, cardiovascular, gastrointestinal, infections, respiratory, inflammation, and neuroscience research.
Idea Evaluation: The management team carefully evaluated the submitted ideas based on predetermined criteria such as feasibility, market potential, alignment with company goals, and customer value. The goal was to select at least three initiatives for further development.
Initiative Selection: Due to the high quality of the proposals received, the management team decided to give the green light to four initiatives instead of the initial target. This decision reflected the enthusiasm and potential impact of the ideas presented.
Intrapreneurship Program: Recognizing the value of ongoing idea generation, AstraZeneca decided to execute an additional pop-up accelerator the following year to generate more innovative ideas. This initiative aimed to further foster employee creativity and expand the pool of potential initiatives.
Outcomes
The collaboration between AstraZeneca and Spyre Group yielded the following outcomes:
Cultivated innovative ecosystem: The project successfully created an environment that encouraged and supported employee-driven innovation within AstraZeneca's Israel division.
Measurable success: By implementing a structured evaluation framework, the management team was able to measure the success and impact of the selected initiatives, providing insights for future decision-making and resource allocation.
Value creation: The initiatives selected demonstrated significant potential to deliver value to customers, patients, and healthcare providers, aligning with AstraZeneca's mission of improving healthcare outcomes.
Continued innovation: The decision to execute an additional pop-up accelerator reflected the commitment to fostering ongoing idea generation and maintaining a culture of innovation within the organization.
.svg){kind=icon}
